e-limbo, e-zine de informacion y analasis de modos de vida actual
22.03.2018 / Sesión no Iniciada 

 _enviar articulo

e-mail emisor
e-mail receptor
Ayúdanos a evitar contactos automáticos
Anti Spam

En estos tiempos de hipercomunicación bastaría la invitación de enviar a un amigo cualquiera de los textos que consideres interesantes algo redundante: demasiada comunicación, demasiados textos y , en general, demasiado de todo.
Es posible que estemos de acuerdo... pero cuando encuentras algo interesante en cualquier sitio, la red, la calle, tu casa, o un lugar escondido y remoto, compartirlo no sólo es un acto (acción, hecho) de amistad o altruismo, también es una manera de ahorrar tiempo a los demás (y de que te lo ahorren a ti (si eres afortunado) a costa del tiempo que tu has podido derrochar (emplear) y el gustazo de mostrar que estuviste ahí (o donde fuera ) un poco antes (el tiempo ya no es más el que era).
Comparte con tus conocidos aquello que encuentras, es evolución.
We need a new drug (system)
16-01-06 Suggested by: Terry & The Pirates 


IP-Watch reports today the startling news that a World Health Organization commission on intellectual property rights "failed to meet its deadline" for presenting a report to the WHO executive board this month. The ostensible reason: disagreement among the members of the commission.
OK, OK, I'm kidding. There is nothing at all startling or surprising about this news. In the awesome bureaucracies of institutions like the World Health Organization or the World Trade Organization, nothing ever happens on time. Consensus-building is hard work -- especially when the topic at hand is the issue of how patents affect poor people's access to drugs. And especially when some of the "stakeholders" involved will do everything in their power to thwart meaningful progress.

The WHO Commission on Intellectual Property Rights, Innovation and Public Health (CIPIH) was established in February 2004 "to collect data and proposals from the different actors involved and produce an analysis of intellectual property rights, innovation, and public health, including the question of appropriate funding and incentive mechanisms for the creation of new medicines and other products against diseases that disproportionately affect developing countries..."

Translated into plain language, the commission was entrusted with the job of coming up with proposals on how to balance the desperate need of poor people in poor countries to gain access to expensive drugs, without at the same time trampling over the intellectual property protections that ensure that drug companies have the profit incentive to spend the billions of dollars necessary to create new drugs.

The conflict at the heart of this problem is probably the hottest hot button in the global struggle over intellectual property. In contrast to pirated DVDs of Hollywood movies or reverse-engineered semiconductor chip designs, there is a clear moral aspect to the challenge of dealing properly with sick people who will die because they can't afford a state-of-the-art protease inhibitor for HIV treatment.

In another news report this morning, "Pedro Chequer, head of Brazil's HIV/AIDS program, on Thursday told attendees at a Latin American conference -- which was aimed at discussing strategies on providing access to treatments for HIV/AIDS and other sexually transmitted diseases -- that countries unable to afford antiretrovirals should consider breaking foreign patents and producing the drugs."

Chequer's words embodied no idle threat, and underscored the importance of what the WHO Commission has been tasked with. Brazil is a standard-bearer for the growing number of developing countries that are impatient with patent pressure from rich nations. Brazil has a National AIDS program that guarantees universal access to medicine and treatment. But the high cost of AIDS drugs is a heavy burden to bear, especially when generic versions of those drugs are easy to manufacture for a fraction of the price. Two-thirds of Brazil's Ministry of Health AIDS budget is spent on just three drugs made by Merck, Abbott Laboratories and Gilead Sciences.

Last summer, Brazil precipitated a major patent firestorm when it told Abbott that unless the company lowered its price for Kaletra, a cocktail of protease inhibitors, it would declare a national health emergency and manufacture its own generic versions of the drug, while paying only a minimal royalty. After several months of intense negotiations, Abbott finally gave in, and cut its prices.

For defenders of intellectual property rights in the United States, Brazil's behavior was out-and-out thievery, motivated not by concerns over social justice, but by a desire to establish its own indigenous generic drug industry. Having achieved that, Brazil would then turn around and "fence its stolen goods" to countries in Africa and elsewhere.

Such rhetoric tends to ignore the fact that poor people are dying by the millions around the world because of their lack of access to drugs. But Big Pharma does have an indisputable point. It costs an awful lot of money to successfully develop a new drug. It costs very little to copy an already developed drug. If intellectual property protections didn't exist, why would an Abbott or a Merck bother to create new drugs?

The obvious answer to that is: It isn't the role of private companies to act according to the dictates of social justice concerns. That role properly belongs to government. There must be ways for government to come up with solutions that protect the profit incentive and provide for the needy. The IP-Watch report this morning noted that the CIPIH commission had a Web site that accepted submissions with proposals on how to deal with their mandate. The site is a mother lode of papers that merit long hours of study and reflection. But one in particular caught my eye, "Patents and Essential Medicines: An Application of the Green Intellectual Property Project."

The paper, written by Itaru Nitta, of the School of International Service, American University, suggests a kind of patent insurance fund financed by "reserves, taxes, and premiums" in the patent system itself. This pool of money could then be drawn upon to subsidize access to medicine in developing countries.

The money would come from the fees paid to various patent offices for the processing of patents, from the revenue flow that patent holders derived from royalty payments and infringement compensation, and directly, as a kind of insurance premium from the patent holders. According to the abstract for the paper, "while allowing impoverished nations to access essential medicines ... the system would ensure patent incomes for patent beneficiaries [and] would increase pharmaceutical companies' incentives to develop medicines for poverty-related diseases even when the medicine's users do not have sufficient financial means."

It's a clever idea, although naturally Big Pharma would fight it tooth and nail as an additional cost placed upon their business. Then again, one could argue that if a good solution to the problem isn't found, developing nations like Brazil and India will go ahead with their production of generics and there won't be any money to be made by anyone.

Personally, I'm just beginning to delve into the intricacies of the international intellectual property regime and I can't say with authority whether Nitta's proposal has any likelihood of working. But too often, questions such as the conflict between social justice and the profit incentive are seen as irreconcilable. That can't be accepted: There's always a workaround.

-- Andrew Leonard


Rating: 4 - 1 voto(s).

No existen comentarios.
Comentario / Comment:
  atención: para realizar comentarios tienes que ser usuario registrado.


15-01-12_ "Recapitalizar a los bancos por tener deuda de su país es absurdo"
24-01-11_ Sociedad Estatal de Demoliciones Culturales
18-09-09_ LA comercialización de la cultura
26-10-08_ Solbes: «2009 va a ser peor, no cabe la menor duda»
02-01-09_ The Story of Stuff
05-10-08_ SOROS * entrevista
21-05-08_ Why People Don't Trust Free Markets
02-05-08_ Zimbabue compra por Internet para sortear una inflación del 100.000%
24-03-08_ IDEIA DEKOT * Manual de supervivencia para montártelo por tu cuenta
04-02-08_ ¿'CRACK' 2008?
24-03-08_ Copia privada, ese derecho virtual
24-03-08_ The Pirate's Dilemma: A Review
23-12-07_ Así en la SGAE como en la Iglesia
17-12-07_ Dos asociaciones denuncian que la SGAE financia al poder judicial
16-12-07_ RECIPE: Five Great Lunchbox Favs
25-11-07_ Invitation to the OpenBusiness Community
15-11-07_ Trade-offs of offering content for free
16-11-07_ Climate change * from issue to magnifier
22-10-07_ SGAE: la punta del iceberg de un entramado societario...
02-11-07_ La JUSTICIA y el P2P ( ¡! )
14-09-07_ Executive Compensation: Is This the Beginning of a New Era?
06-07-07_ Collapse: How the U.S. Is Choosing to Fail
26-06-07_ The market function of piracy
24-05-07_ Seven gay wonders of the world
29-08-07_ Designig for Humans Not Users
31-05-07_ Introducing... the starving artist
31-05-07_ Martín Patino liberará su Filmografía.
31-05-07_ People Inside Web 2.0: An Interview with Tim O'Reilly
29-05-07_ Rutas para la innovación abierta: costes, aceleración y creatividad
26-03-07_ WEB 2.0 según TechCrunch
24-03-07_ Arcadi Espada y el Canon
17-03-07_ Ni se le ocurra tatarear a Mozart
15-03-07_ ¿Cómo hacer un blog de economía?
13-03-07_ El brujo de Menlo Park
03-03-07_ Mobile the 7th Mass Media is to internet like TV is to radio
23-02-07_ Hacia el fin del COPYRIGHT
18-02-07_  Shit Help Bad Hot Army Boom Kill!!! 
07-02-07_ Pensamientos sobre la música * Steve Jobs
04-02-07_ MOD Films
03-02-07_ Si no te conectas es por que no quieres...
30-01-07_ Emerging Art Markets
27-01-07_ The "special interests" destroying China's environment
17-01-07_ La SGAE vista desde dentro...
16-01-07_ Interview * Michael Bauwens
10-01-07_ Pero plagiar es otra cosa
04-01-07_ Amenazas a la información

04-01-07_ Los Múltiples retos de la innovación
28-12-06_ Comprando Burgos, La ciudad...
25-12-06_ The inexplicable inexistence of Real Madrid
11-12-06_ Openstudio * Experimento en creatividad, colaboración y capitalismo.
03-12-06_ Open Business re-crea la comunidad
27-11-06_ Cafuné breaking the limits for Open Business models
23-11-06_  Business Model Template Hacking
18-11-06_ O.J. Simpson, News Corp, and Milton Friedman
13-11-06_ Stray Cinema
01-11-06_Del Elitismo de la Web 1.0 a la Burbuja 2.0
01-11-06_How Non-Commercial Licenses make Business
26-10-06_He vuelto de Ikea y mi único deseo es matar (I)
25-10-06_A new idea about Opening Business
19-10-06_Revver - Openbusiness New Sponsor
08-10-06_Is Your Personality the Ticket to Financial Freedom?
30-09-06_The Wrong Gallery * The greatest little gallery on earth
22-09-06_el sin-sentido de las patentes
21-09-06_Open Business Meets Filmaking
16-09-06_IndieKarma * a new way to get paid for blogging
09-09-06_Revolution at our fingertips
08-09-06_La 'wikimanía' se extiende por la Red
01-09-06_Copyright Criminals: This is a Sampling Sport
31-08-06_Man From Google Joins Apple’s Board
18-08-06_Patents for profit: dystopian visions of the new economy
13-08-06_The cluetrain manifesto
10-08-06_Depositos finacieros, vivienda y deducción fiscal
07-08-06_YOU TUBE * me watch
05-08-06_Reunión mundial de piratas informáticos en Las Vegas
04-08-06_Lo que les preocupa a los poderosos
13-03-07_ Ya hay más de 500.000 firmas contra el canon digital
23-07-06_Con la moral por delante
22-07-06_Gateway to Nowhere?
21-07-06_Industria musical y cultura libre: hoy en el CCCB
30-06-06_People Power
15-06-06_El futuro del libro: líquido o en la Red
13-06-06_Casas que están vivas
05-06-06_The fall and rise of Kate Moss
24-05-06_Primera Gran Guerra por el control de la Red
23-05-06_The sunset stalker: Bono
06-06-06_The greedy truth about media consultants
07-06-06_Making meaning from our own stories (Selflore) in the age of discontinuity
22-04-06_La crítica en la era del capitalismo cultural electrónico
05-04-06_La SGAE bate su propio récord de ingresos... y +++
29-03-06_How Copyright Law Changed Hip Hop
03-05-06_China acapara ya el 19% de las reservas internacionales de divisas
25-03-06_Intellectual Property roundup
24-03-06_De Gutenberg a Amazon: cómo convertirse en autor de verdad, sin salir de casa
19-03-06_La mala política energética de Bush
17-03-06_Los estudiantes franceses vuelven a la calle
16-03-06_Brent Hoberman:
06-03-06_Los ‘sukuk’, o cómo invertir sin ofender los mandamientos del profeta
06-03-06_More power to you
18-02-06_I Do, I Do, I Do, I Do
02-03-06_Trabajo afectivo
13-02-06_El parlamento de las cosas
19-03-06_Entrevista: Sabine Breitwieser
07-02-06_El dividendo del arte
03-02-06_Adieu Alan, Bonjour Ben, Welcome Transparency
30-01-06_ Prescribing Drugs a Healthy Future
20-01-06_Vers la décroissance: Écofascisme ou écodémocratie
27-01-06_The New Market Bubble Theory
16-01-06_We need a new drug (system)
13-01-06_Garçon! Un Coca-Cola, S'il Vous Plaît
09-01-06_Weather Has Become Bogeyman, News Staple
07-01-06_La inmigración en España / Una obsesión desbordada
04-01-06_Novel Thinking as a Survival Tactic
27-12-05_África, un desacuerdo navideño con Bono
23-12-05_America's most-hated companies
21-12-05_¡Tu Mismo!
03-12-05_El bajo perfil de España en Estados Unidos
29-09-05_Infinita Avaricia
22-06-05_Por ahí
09-06-05_¡Tu Mismo!



Regístrate y disfruta de utilidades de administración y gestión de los contenidos de e-limbo*
Recibe las novedades en tu correo electronico.
El futuro está escrito en las estrellas... Horóscopo creado por J.G. Ballard y dedicado a todos vosotros.
Aplicaciones y herramientas necesarias para navegar y utilizar los contenidos del limbo electrónico e internet (www).
Artículos de e-limbo* en formato PDF preparados para viajar y aportar información allá donde estés. (y seguir salvando árboles)

_e-limbo * apoya



Mais uma edição do podcast Música Livre para o Archivo Vivo, do Centro Cultural da Espanha/AECID. ...
Ante preguntas de oyentes y amigos, puedo responder ahora que Vía Límite continuará en Radio ...
SORPRESA¡!¡! An unreleased version of Talking Heads' "Psycho Killer" with Arthur Russell on cello
Optimizado: Firefox, Safari, Mozilla, Netscape, Konqueror, Explorer. Resolución óptima: 1024x768
ISSN: 1885-5229    Aviso Legal e-limbo.org*